Covered recipient · General Payments record
DAVID E OAKLEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,194.36
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $389.97 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $94.73 | 4 |
| Amgen Inc. | $41.24 | 2 |
| Lilly USA, LLC | $35.13 | 2 |
| PFIZER INC. | $34.73 | 2 |
| Novo Nordisk AS | $34.02 | 2 |
| Acerta Pharma LLC | $32.55 | 2 |
| Corium, Inc. | $21.53 | 1 |
| Antares Pharma, Inc. | $17.69 | 1 |
| Daiichi Sankyo Inc. | $17.04 | 1 |
| Astellas Pharma US Inc | $16.85 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.54 | 1 |
| BAXTER HEALTHCARE | $14.27 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.63 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142518 | CMS |
| ABBVIE INC. | $17.33 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142520 | CMS |
| ABBVIE INC. | $23.38 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142522 | CMS |
| ABBVIE INC. | $29.39 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142524 | CMS |
| Amgen Inc. | $24.12 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111663937 | CMS |
| Amgen Inc. | $17.12 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111663939 | CMS |
| Antares Pharma, Inc. | $17.69 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146476740 | CMS |
| Astellas Pharma US Inc | $16.85 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139283864 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.06 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104688818 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.49 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105895806 | CMS |
| Baxter Healthcare | $14.27 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120633306 | CMS |
| Corium, LLC | $21.53 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100218697 | CMS |
| Daiichi Sankyo Inc. | $17.04 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089463718 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101702130 | CMS |
| Lilly USA, LLC | $19.20 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136152307 | CMS |
| Lilly USA, LLC | $15.93 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136131686 | CMS |
| Novo Nordisk Inc | $16.97 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097581258 | CMS |
| Novo Nordisk Inc | $17.05 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097735971 | CMS |
| PFIZER INC. | $13.43 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131425957 | CMS |
| PFIZER INC. | $21.30 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142664537 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.54 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144592062 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.